Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

42.65
BATS BZX Real-Time Price
As of 3:04pm ET
 +0.14 / +0.33%
Today’s Change
36.81
Today|||52-Week Range
44.50
+5.46%
Year-to-Date
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat
10:27am / Zacks.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb 15 / Zacks.com - Paid Partner Content
ImmunoGen, Inc.: Waiting to Move FORWARD
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Morgan Stanley, General Motors, Prudential Financi...
Feb 13 / Zacks.com - Paid Partner Content
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Feb 19 / MotleyFool.com - Paid Partner Content
Flu Death Rates Just Hit the Epidemic Threshold, but This Is the Real Shocker
Feb 11 / MotleyFool.com - Paid Partner Content
Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta
Feb 17 / TheStreet.com - Paid Partner Content
Top Analyst Reports for Morgan Stanley, GM & Prudential
Feb 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.51
Today’s open42.24
Day’s range42.24 - 42.83
Volume62,680
Average volume (3 months)2,077,362
Market cap$109.4B
Dividend yield3.70%
Data as of 3:04pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.20%
Revenue growth (last year)-2.08%
P/E ratio25.5
Price/Sales2.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.02-0.04%
ABBVAbbVie-0.31-0.50%
BMYBristol-Myers Squibb+0.39+0.70%
CELGCelgene-1.98-1.66%
Data as of 3:04pm ET, 02/24/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts


Search for Jobs